What does this video actually claim?
Joey Szatmary's post suggests testosterone replacement therapy (TRT) is connected to a mental health "battle that no one is talking about" and includes a suicide prevention hotline. The implication is that TRT relates to depression or suicide risk, though he doesn't make explicit claims.
The video's vague framing makes it hard to fact-check specific statements. Szatmary appears to be discussing mental health struggles in the TRT community, but without clear assertions about causation or treatment effects.
What does research show about TRT and depression?
The relationship between testosterone and mood is complex and bidirectional. The Testosterone Trials (Snyder et al., NEJM, 2016) found modest improvements in mood scores among older men with low testosterone, but didn't study clinical depression specifically.
A 2018 meta-analysis by Walther et al. in Psychoneuroendocrinology showed testosterone therapy reduced depressive symptoms in hypogonadal men by about 1.5 points on depression scales. However, these weren't men with major depressive disorder.
The picture gets murkier when you consider that some men use TRT without medical supervision. Discontinuing testosterone after long-term use can cause temporary mood crashes as natural production restarts.
What are the real mental health risks?
The biggest psychiatric concern with testosterone isn't depression but potential mood swings during treatment. Studies show irritability and aggressive behavior can increase, especially with higher doses or fluctuating levels.
More concerning is what happens when men stop TRT abruptly. The post-cycle depression that bodybuilders experience when discontinuing anabolic steroids is well-documented, though less studied in medical TRT patients.
There's also selection bias to consider. Men seeking TRT often already have mood symptoms, fatigue, or life stressors that brought them to treatment in the first place.
What should you actually know about TRT and mood?
TRT can help mood symptoms in men with clinically low testosterone (typically below 300 ng/dL), but it's not an antidepressant. The Testosterone Trials showed benefits mainly in men with baseline testosterone under 275 ng/dL.
If you're considering TRT primarily for depression, that's the wrong approach. Standard depression treatments like therapy and SSRIs have much stronger evidence. TRT should address documented hypogonadism first, with mood benefits being secondary.
The suicide prevention hotline inclusion suggests Szatmary recognizes real mental health struggles in his audience. That's responsible, even if his TRT framing lacks nuance. Anyone having suicidal thoughts should contact the 988 Suicide & Crisis Lifeline immediately.